| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |